By Ms Katrina Blazek

Journal articles

Ryzhakov G; Blazek K; Udalova IA, 2011, 'Evolution of vertebrate immunity: Sequence and functional analysis of the SEFIR domain family member Act1', Journal of Molecular Evolution, 72, pp. 521 - 530, http://dx.doi.org/10.1007/s00239-011-9450-7

Krausgruber T; Blazek K; Smallie T; Alzabin S; Lockstone H; Sahgal N; Hussell T; Feldmann M; Udalova IA, 2011, 'IRF5 promotes inflammatory macrophage polarization and T H1-TH17 responses', Nature Immunology, 12, pp. 231 - 238, http://dx.doi.org/10.1038/ni.1990

Lee HJ; Hinshelwood R; Bouras T; Gallego-Ortega D; Valdes-Mora F; Blazek K; Visvader JE; Clark SJ; Ormandy CJ, 2011, 'Lineage specific methylation of the Elf5 promoter in mammary epithelial cells', Stem Cells, 29, pp. 1611 - 1619, http://dx.doi.org/10.1002/stem.706

Krausgruber T; Saliba D; Eames H; Williams L; Smallie T; Blazek K; Udalova IA, 2011, 'PS2-062. Novel role of IRF5 in transcriptional inhibition of human IL-10 gene expression', Cytokine, 56, pp. 81 - 81, http://dx.doi.org/10.1016/j.cyto.2011.07.224

Krausgruber T; Saliba D; Ryzhakov G; Lanfrancotti A; Blazek K; Udalova IA, 2010, 'IRF5 is required for late-phase TNF secretion by human dendritic cells', Blood, 115, pp. 4421 - 4430, http://dx.doi.org/10.1182/blood-2010-01-263020

Ryzhakov G; Lai C; Blazek K; Udalova I, 2010, 'PS1-75 IL-17 stimulation results in a pro-inflammatory outcome during antiviral response in human cells', Cytokine, 52, pp. 33 - 33, http://dx.doi.org/10.1016/j.cyto.2010.07.147

Krausgruber T; Saliba D; Blazek K; Lockstone H; Sahgal N; Alzabin S; Teixeira A; Hussell T; Ragoussis J; Udalova IA, 2010, 'SS5-2 IRF5 as a defining factor of M1 macrophage polarization', Cytokine, 52, pp. 44 - 44, http://dx.doi.org/10.1016/j.cyto.2010.07.185

Hilton HN; Kalyuga M; Cowley MJ; Alles MC; Lee HJ; Caldon CE; Blazek K; Kaplan W; Musgrove EA; Daly RJ; Naylor MJ; Graham JD; Clarke CL; Ormandy CJ, 2010, 'The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5.', Mol Endocrinol, 24, pp. 1380 - 1392, http://dx.doi.org/10.1210/me.2009-0516

Oakes SR; Naylor MJ; Asselin-Labat M-L; Blazek KD; Gardiner-Garden M; Hilton HN; Kazlauskas M; Pritchard MA; Chodosh LA; Pfeffer PL; Lindeman GJ; Visvader JE; Ormandy CJ, 2008, 'The Ets transcription factor Elf5 specifies mammary alveolar cell fate.', Genes Dev, 22, pp. 581 - 586, http://dx.doi.org/10.1101/gad.1614608

Craven AJ; Nixon AJ; Ashby MG; Ormandy CJ; Blazek K; Wilkins RJ; Pearson AJ, 2006, 'Prolactin delays hair regrowth in mice', Journal of Endocrinology, 191, pp. 415 - 425

Harris J; Stanford PM; Sutherland K; Oakes SR; Naylor MJ; Robertson FG; Blazek KD; Kazlauskas M; Hilton HN; Wittlin S; Alexander WS; Lindeman GJ; Visvader JE; Ormandy CJ, 2006, 'Socs2 and elf5 mediate prolactin-induced mammary gland development.', Mol Endocrinol, 20, pp. 1177 - 1187, http://dx.doi.org/10.1210/me.2005-0473

Naylor MJ; Oakes SR; Gardiner-Garden M; Harris J; Blazek K; Ho TWC; Li FC; Wynick D; Walker AM; Ormandy CJ, 2005, 'Transcriptional changes underlying the secretory activation phase of mammary gland development.', Mol Endocrinol, 19, pp. 1868 - 1883, http://dx.doi.org/10.1210/me.2004-0254

Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD, 2004, 'Mouse mammary tumor like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer', Clinical Cancer Research, 10, pp. 4417 - 4419

Back to profile page